five

A KLF2-BMPER-Smad1/5 checkpoint regulates high fluid shear stress-mediated artery remodeling

收藏
NIAID Data Ecosystem2026-05-02 收录
下载链接:
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267813
下载链接
链接失效反馈
官方服务:
资源简介:
Vascular remodeling to match arterial diameter to tissue metabolic requirements commonly fails in ischemic disease. Endothelial cells (EC) sense fluid shear stress (FSS) from blood flow to maintain FSS within a narrow range in healthy vessels. Higher FSS induces vessel outward remodeling to return FSS to physiological levels, but mechanisms are poorly understood. We previously reported that Smad1/5 is maximally activated at physiological FSS and suppressed at higher flow. The Smad1/5 pathway opposes activation of Akt, suggesting that inhibiting Smad1/5 may be required for outward remodeling. Here, we report that suppression of Smad1/5 at high FSS is mediated by elevated KLF2, which induces the BMP pathway inhibitor BMPER, which suppresses Smad1/5 and de-inhibits Akt. In a mouse arteriovenous fistula (AVF) model, high FSS induces arterial outward remodeling coincident with elevated BMPER expression and Smad1/5 inactivation. Endothelial BMPER deletion impaired blood flow recovery and vascular remodeling in the AVF and a hindlimb ischemia (HLI) model, with the latter reversed by BMP9/10 blocking antibodies (bAbs). In both STZ-induced type 1 and HFD-induced type 2 diabetic mice that show poor recovery from HLI, BMP9/10 bAbs improved outcomes. Thus, suppression of Smad1/5 is required for high FSS-mediated outward remodeling and is a potential therapeutic approach for ischemic disease. Human umbilical vein endothelial cells (HUVECs) were transfected with Ctrl (siCtrl) or KLF2 (siKLF2) siRNA for 4 days, total RNA was extracted and subjected to RNAseq, n=4 samples for each group.

在缺血性疾病中,匹配动脉直径与组织代谢需求的血管重构通常会失效。内皮细胞(Endothelial cells, EC)可感知血流产生的流体切应力(Fluid Shear Stress, FSS),在健康血管中将FSS维持在狭窄的生理区间内。当FSS升高时,血管会发生外向性重构以将FSS恢复至生理水平,但其具体分子机制尚不清楚。我们此前的研究表明,Smad1/5在生理性FSS下被最大程度激活,而在高流量状态下则被抑制。Smad1/5通路可拮抗Akt的激活,这提示外向性重构可能需要抑制Smad1/5的活性。本研究发现,高FSS下Smad1/5的抑制作用由表达上调的KLF2介导:KLF2可诱导骨形态发生蛋白(Bone Morphogenetic Protein, BMP)通路抑制剂BMPER的表达,而BMPER可抑制Smad1/5,从而解除其对Akt的抑制作用。在小鼠动静脉瘘(Arteriovenous Fistula, AVF)模型中,高FSS可诱导动脉外向性重构,同时伴随BMPER表达上调与Smad1/5失活。在内皮细胞中敲除BMPER会损害AVF模型与后肢缺血(Hindlimb Ischemia, HLI)模型中的血流恢复与血管重构,而后肢缺血模型的表型可通过BMP9/10封闭抗体(Blocking Antibodies, bAbs)得到逆转。在链脲佐菌素(Streptozocin, STZ)诱导的1型糖尿病小鼠与高脂饮食(High Fat Diet, HFD)诱导的2型糖尿病小鼠中,HLI后的血流恢复均较差,而BMP9/10封闭抗体可改善其预后。综上,高FSS介导的外向性重构需要Smad1/5的抑制作用,这为缺血性疾病提供了一种潜在的治疗策略。将人脐静脉内皮细胞(Human Umbilical Vein Endothelial Cells, HUVECs)分别转染阴性对照小干扰RNA(siCtrl)与KLF2靶向小干扰RNA(siKLF2),培养4天后提取总RNA并进行RNA测序,每组设置4个生物学重复样本。
创建时间:
2024-08-29
二维码
社区交流群
二维码
科研交流群
商业服务